Cash Flow | Glaxosmithkline Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2159.50-9.5 (-0.44 %)
PREV CLOSE (Rs.) 2169.00
OPEN PRICE (Rs.) 2173.50
BID PRICE (QTY) 2160.45 (1)
OFFER PRICE (QTY) 2163.00 (12)
VOLUME 1298
TODAY'S LOW / HIGH (Rs.)2158.30 2186.90
52 WK LOW / HIGH (Rs.)1228 2649.95
NSE2160.25-10.55 (-0.49 %)
PREV CLOSE( Rs. ) 2170.80
OPEN PRICE (Rs.) 2170.85
BID PRICE (QTY) 2160.25 (1)
OFFER PRICE (QTY) 2162.25 (2)
VOLUME 50796
TODAY'S LOW / HIGH(Rs.) 2157.00 2188.00
52 WK LOW / HIGH (Rs.)1227 2524

Cash Flow

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax8414.9424756.487230.956472.466539.70
Adjustment-400.03-16364.84-256.41131.71-313.63
Changes In working Capital-457.461198.72457.46440.68-41.93
Cash Flow after changes in Working Capital7557.469590.367432.007044.856184.14
Cash Flow from Operating Activities4842.258107.485779.114905.004094.87
Cash Flow from Investing Activities8078.51-4055.084180.26-568.43-1534.53
Cash Flow from Financing Activities-15433.23-5242.42-6955.60-4276.22-3583.59
Net Cash Inflow / Outflow-2512.46-1190.023003.7860.35-1023.25
Opening Cash & Cash Equivalents2861.874051.891048.12987.772011.02
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent349.412861.874051.891048.12987.77